<unk>  and<unk><unk>  of hemophilia include co-transplantation of endothelial colony-forming cells (ECFCs) and placenta-derived mesenchymal stromal cells (PMSCs) at the neonatal age and prevention of the anti-factor VIII memory B-cell response.
Hemophilia future or investigational therapies
Hemophilia A future or investigational therapies
Thrombophilia primary prevention
Hemophilia primary prevention
Hemophilia secondary prevention
Thrombophilia secondary prevention
Heparin-induced thrombocytopenia future or investigational therapies
Thrombophilia medical therapy